Page last updated: 2024-10-22

acetaminophen and Hypertrophy

acetaminophen has been researched along with Hypertrophy in 5 studies

Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.

Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).

Research Excerpts

ExcerptRelevanceReference
"Sepsis and acute liver failure are associated with severe endogenous intoxication."1.72Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study. ( Hayden, MR; Shulyatnikova, T; Tumanskyi, V, 2022)
"Acetaminophen was added to the basal diet at 0, 80, 253, 800, 2530, or 8000 ppm and administered to type 2 diabetes mellitus rats (GK/Jcl) and the control male rats (Wistar) for 13 weeks."1.56Preexisting diabetes mellitus had no effect on the no-observed-adverse-effect-level of acetaminophen in rats. ( Hashimoto, N; Imaida, K; Kanie, S; Kishi, S; Matsuda, Y; Nakano-Narusawa, Y; Saoo, K; Yamakawa, K; Yokohira, M, 2020)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Shulyatnikova, T3
Tumanskyi, V3
Hayden, MR3
Kishi, S1
Yamakawa, K1
Nakano-Narusawa, Y1
Kanie, S1
Hashimoto, N1
Saoo, K1
Yokohira, M1
Imaida, K1
Matsuda, Y1
Vordenbäumen, S1
Groiss, SJ1
Dihné, M1
Amacher, DE1
Adler, R1
Herath, A1
Townsend, RR1
Jia, Y1
Guo, GL1
Surapureddi, S1
Sarkar, J1
Qi, C1
Guo, D1
Xia, J1
Kashireddi, P1
Yu, S1
Cho, YW1
Rao, MS1
Kemper, B1
Ge, K1
Gonzalez, FJ1
Reddy, JK1

Other Studies

5 other studies available for acetaminophen and Hypertrophy

ArticleYear
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Reactive Microgliosis in Sepsis-Associated and Acute Hepatic Encephalopathies: An Ultrastructural Study.
    International journal of molecular sciences, 2022, Nov-21, Volume: 23, Issue:22

    Topics: Acetaminophen; Animals; Delirium; Hepatic Encephalopathy; Hypertrophy; Liver Failure; Neurotoxicity

2022
Preexisting diabetes mellitus had no effect on the no-observed-adverse-effect-level of acetaminophen in rats.
    The Journal of toxicological sciences, 2020, Volume: 45, Issue:3

    Topics: Acetaminophen; Animals; Diabetes Mellitus, Type 2; Hepatocytes; Hypertrophy; Male; No-Observed-Adver

2020
Isolated unilateral temporal muscle hypertrophy: a rare cause of hemicranial headache.
    Headache, 2009, Volume: 49, Issue:5

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Diagnosis, Differential; Female; Functional Laterality; Hum

2009
Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy.
    Clinical chemistry, 2005, Volume: 51, Issue:10

    Topics: 1-Naphthylisothiocyanate; Acetaminophen; Animals; Biomarkers; Chemical and Drug Induced Liver Injury

2005
Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity.
    Proceedings of the National Academy of Sciences of the United States of America, 2005, Aug-30, Volume: 102, Issue:35

    Topics: Acetaminophen; Animals; Base Sequence; Constitutive Androstane Receptor; DNA; Gene Expression; Hyper

2005